Explore 3 Stock Ideas & Industry Insights Download Free Report

Gelteq Limited Ordinary Shares

Company price
0.2816 USD -0.08 ( 21.54%)
Last update at 2026-11-17T17:44:00Z
VOLUME
76841
Market Cap
6.59M

Momentum Score

…

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.26
Low
0.33
High
52 Week Price Range
0.39
Low
2.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Gelteq Limited (ticker GELS) are limited and the company's core operations, revenue model and product offerings are not well documented in widely available filings or analyst coverage. Because detailed long-term growth drivers and strategy are not publicly clear, investors may find the stock's potential contingent on forthcoming disclosures that demonstrate a scalable business model and credible execution.

The primary investment risk is the substantial information gap—limited transparency creates execution, financing and valuation uncertainty that could lead to significant share-price volatility.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.36
Dividend Yield
-
Revenue TTM
0.47M
Revenue Per Share
0.05
Gross Profit TTM
0.36M
Debt / Equity
0.27
ROE
-42.93%
Net Debt
3.87M
ROCE
-29.99%
Diluted EPS TTM
-0.52

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Income before tax -6.65M -3.55M -3.51M -3.37M -0.65M
Net income -6.65M -3.55M -3.51M -3.37M -0.65M
Selling general administrative 2.02M 1.25M 1.53M 1.48M 0.45M
Selling and marketing expenses 0.20M 0.02M 0.17M 0.07M 0.01M
Gross profit 0.17M 0.00M 0.03M 0.05M 0.00M
Reconciled depreciation 1.22M 1.21M 1.23M 1.22M 0.06M
Ebit -4.75M -2.96M -3.10M -3.19M -0.65M
Ebitda -3.53M -1.75M -1.88M -1.98M -0.59M
Depreciation and amortization 1.22M 1.21M 1.23M 1.22M 0.06M
Operating income -5.50M -2.95M -3.10M -3.19M -0.65M
Other operating expenses 5.66M 2.95M 3.18M 3.34M 0.65M
Interest expense 1.89M 0.59M 0.40M 0.17M 0.00M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Net interest income -1.95M -0.60M -0.40M -0.18M -0.00M
Total revenue 0.17M 0.00M 0.08M 0.15M 0.00M
Total operating expenses 5.66M 2.95M 3.13M 3.25M 0.65M
Cost of revenue - 0.00M 0.05M 0.09M 0.00M
Total other income expense net -1.15M -0.60M -0.40M -0.18M -0.00M
Net income from continuing ops -6.65M -3.55M -3.51M -3.37M -0.65M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Total assets 21.48M 20.76M 22.49M 23.41M 24.22M
Intangible assets 19.86M 20.44M 21.49M 22.65M 23.84M
Other current assets 0.70M 0.10M 0.15M 0.21M -
Total liab 5.67M 5.65M 3.84M 2.55M 0.40M
Total stockholder equity 15.80M 15.11M 18.66M 20.86M 23.82M
Other current liab 1.09M 0.92M 0.88M 0.66M 0.12M
Common stock 33.95M 26.61M 26.61M 25.30M 24.93M
Capital stock 33.95M 26.61M 26.61M 25.30M 24.93M
Retained earnings -18.14M -11.50M -7.95M -4.48M -1.11M
Cash 0.34M 0.02M 0.40M 0.16M 0.18M
Total current liabilities 5.63M 3.87M 1.36M 1.08M 0.24M
Current deferred revenue - 0.13M 0.09M 0.12M -
Net debt 3.87M 3.82M 2.09M 1.35M -0.01M
Short term debt 4.20M 2.08M 0.02M 0.04M 0.00M
Short long term debt 4.20M 2.08M 0.01M 0.01M 0.00M
Short long term debt total 4.22M 3.84M 2.49M 1.51M 0.17M
Total current assets 1.51M 0.30M 0.99M 0.72M 0.37M
Net receivables 0.46M 0.18M 0.35M 0.25M 0.19M
Long term debt 0.01M 1.76M 2.47M 1.46M 0.17M
Inventory - 0.00M 0.10M 0.10M 0.00M
Accounts payable 0.18M 0.39M 0.29M 0.22M 0.09M
Accumulated other comprehensive income - - - 0.03M -
Non currrent assets other 0.09M - - - -
Non current assets total 19.97M 20.45M 21.50M 22.69M 23.84M
Capital lease obligations - 0.00M 0.01M 0.05M 0.00M
Breakdown 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Type yearly yearly yearly yearly yearly
Date 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Investments -0.74M -0.15M -0.08M 0.00M 0.14M
Total cashflows from investing activities -0.74M -0.15M -0.08M - 0.14M
Net borrowings 0.48M 0.84M 0.72M 1.49M -
Total cash from financing activities 6.45M 0.84M 2.03M 1.49M 0.00M
Net income -6.65M -3.55M -3.51M -3.37M -0.65M
Change in cash 0.32M -0.37M 0.24M -0.02M -0.14M
Begin period cash flow 0.02M 0.40M 0.16M 0.18M 0.32M
End period cash flow 0.34M 0.02M 0.40M 0.16M 0.18M
Total cash from operating activities -5.52M -1.07M -1.77M - -
Issuance of capital stock 7.91M 0.00M 1.43M 0.00M 0.00M
Other cashflows from investing activities -0.73M -0.15M -0.04M - -
Other cashflows from financing activities -1.94M - -0.12M - -
Capital expenditures 0.64M 0.15M 0.08M 0.00M 0.00M
Other non cash items -5.52M 2.48M 1.74M - -
Free cash flow -6.16M -1.22M -1.85M -1.51M -0.28M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
GELS
Gelteq Limited Ordinary Shares
-0.08
21.54%
0.28 - - 13.98 0.71 92.13
MKKGY
Merck KGaA ADR
0.30
0.92%
33.03 21.25 14.93 3.10 2.14 3.60
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-
-%
169.65 24.86 15.11 3.13 1.98 3.08
TAK
Takeda Pharmaceutical Co Ltd ADR
0.11
0.51%
21.70 - 10.96 0.01 1.20 2.94
TKPHF
Takeda Pharmaceutical Co. Ltd.
-
-%
43.15 - 10.66 0.01 1.16 2.94

Profile*

Gelteq Limited Ordinary Shares

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Monash Innovation Labs, Clayton, VIC, Australia, 3800

61 3 9087 3990

7

Name Title Year Born
Mr. Nathan Jacob Givoni Co-Founder, CEO & Executive Director 1984
Mr. Simon Hayden Szewach Co-Founder & Non-Executive Chairman 1980
Ms. Thuy-Linh Gigler Chief Financial Officer 1980
Dr. Paul M. Wynne Ph.D. Chief Scientific Officer 1963
Bradley Glenn Karp Head of Sales & Marketing NA
Mr. Adam Bendell President of U.S. Operations NA
Mr. Matthew Jones Head of Sports Performance NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…